Literature DB >> 11477529

Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole antifungals.

B Mathema1, E Cross, E Dun, S Park, J Bedell, B Slade, M Williams, L Riley, V Chaturvedi, D S Perlin.   

Abstract

We enrolled 382 college-age women in a cross-sectional survey to investigate the relationship between use of over-the-counter (OTC) azole-based antifungal drugs and vaginal colonization by drug-resistant Candida. This study showed no correlation (P=.506) between previous OTC exposure and colonization of drug-resistant Candida in vaginal flora. However, a small number of resistant Candida species isolates were obtained from women with a history of multiple exposures to OTC antifungals; given the widespread use of these products, this may be an emerging concern.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477529     DOI: 10.1086/322600

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  Management of recurrent vulvovaginal candidiasis: unresolved issues.

Authors:  Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2006-11       Impact factor: 3.725

2.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

3.  The Vaginal Microbiota and Behavioral Factors Associated With Genital Candida albicans Detection in Reproductive-Age Women.

Authors:  Sarah E Brown; Jennifer A Schwartz; Courtney K Robinson; D Elizabeth OʼHanlon; L Latéy Bradford; Xin He; Katrina S Mark; Vincent M Bruno; Jacques Ravel; Rebecca M Brotman
Journal:  Sex Transm Dis       Date:  2019-11       Impact factor: 2.830

4.  Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics.

Authors:  Marie V Pirotta; Suzanne M Garland
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

5.  Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China.

Authors:  Shu-Hua Ge; Zhe Wan; Juan Li; Jianping Xu; Ruo-Yu Li; Feng-Yan Bai
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

6.  Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.

Authors:  Sandra S Richter; Rudolph P Galask; Shawn A Messer; Richard J Hollis; Daniel J Diekema; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

7.  Epidemiology and antifungal susceptibilities of yeasts causing vulvovaginitis in a teaching hospital.

Authors:  Soledad Gamarra; Susana Morano; Catiana Dudiuk; Estefanía Mancilla; María Elena Nardin; Emilce de Los Angeles Méndez; Guillermo Garcia-Effron
Journal:  Mycopathologia       Date:  2014-07-09       Impact factor: 2.574

8.  Hospital use of systemic antifungal drugs.

Authors:  Katja de With; Michaela Steib-Bauert; Holger Knoth; Frank Dörje; Egid Strehl; Ulrich Rothe; Ludwig Maier; Winfried V Kern
Journal:  BMC Clin Pharmacol       Date:  2005-02-10

9.  Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.

Authors:  S Y Chew; Y K Cheah; H F Seow; D Sandai; L T L Than
Journal:  J Appl Microbiol       Date:  2015-03-16       Impact factor: 3.772

10.  Vaginal lactobacilli as potential probiotics against Candida SPP.

Authors:  Natalia F Gil; Rafael C R Martinez; Bruna C Gomes; Auro Nomizo; Elaine C P De Martinis
Journal:  Braz J Microbiol       Date:  2010-03-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.